phrykt

Quest Diagnostics (DGX) cash: $420M

Quest Diagnostics held $420M in cash and cash equivalents on Dec 31, 2025, down 23.5% from $549M a year earlier.

From Quest Diagnostics's filings with the SEC · Read the filing · DGX stock page

Quest Diagnostics cash by year

$872M2021$315M2022$686M2023$549M2024$420M2025

#981 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$420M-23%
Dec 31, 2024$549M-20%
Dec 31, 2023$686M+118%
Dec 31, 2022$315M-64%
Dec 31, 2021$872M–

Cash of similar companies

Companies in the same industry as Quest Diagnostics, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
RadNet$767MDec 31, 2025
Labcorp$532MDec 31, 2025
BillionToOne$496MDec 31, 2025
Quest Diagnostics$420MDec 31, 2025
Guardant Health$378MDec 31, 2025
Veracyte$363MDec 31, 2025
GRAIL$250MDec 31, 2025

Questions and answers

What is Quest Diagnostics's cash?

Quest Diagnostics held $420M in cash and cash equivalents on Dec 31, 2025, down 23.5% from $549M a year earlier.

Numbers as reported in Quest Diagnostics's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology